Form 4: Lipocine CEO Mahesh V. Patel Reports Stock Award and Disposal
SEC Form 4 Filing
Lipocine's CEO, Mahesh V. Patel, reports the acquisition of 4,893 shares of common stock and disposal of 112,311 shares.
Summary
- On March 8, 2024, Mahesh V. Patel, CEO and President of Lipocine Inc., reported a transaction involving the company's common stock.
- Patel acquired 4,893 shares of common stock.
- Patel also disposed of 112,311 shares of common stock.
- The acquisition was related to restricted stock units that vest over time.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by an insider, neither particularly positive nor negative.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to the market.
Stakeholder Impact
- Shareholders are informed about the CEO's stock transactions.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of stock acquisition and disposal. |
| 03/08/2025 | First vesting date for 1/3 of the restricted stock units. |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.